Agronova Biotech centralises the production of its microalgae hydrolysate at its headquarters in Molina de Segura (Spain)

Centralising the production process improves efficiency, increases manufacturing capacity and ensures greater batch-to-batch consistency.

Agronova Biotech continues to strengthen its industrial capabilities by centralising the production of its microalgae hydrolysate at its headquarters in Molina de Segura (Murcia, Spain). The process, which was previously carried out at the Fortuna (Murcia) facilities, has been moved to the company’s head office with the aim of concentrating production resources in a single centre with greater technological capabilities. This reorganisation makes it possible to optimise the different manufacturing stages and improve operational efficiency.

Centralising production makes it possible to manufacture larger batches with greater consistency, ensuring constant quality and optimising production times. In addition, the improvements incorporated into the facilities promote greater energy efficiency and more efficient use of resources, contributing to a more sustainable production process.

With this improvement, Agronova Biotech continues to drive innovation in its industrial processes to offer biotechnology solutions of the highest quality, reinforcing its commitment to efficiency, sustainability and production excellence.